Condition: Depressive Disorder, Major · Sponsor: Janssen Research & Development, LLC
The purpose of this study is to evaluate how well JNJ-89495120 works (anti-depressant effects) and how well it is tolerated as compared to placebo on reducing the symptoms of depression in participants with major depressive disorder (MDD).
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UAB Huntsville Regional Medical Campus | Huntsville, Alabama, United States | — |
| Chandler Clinical Trials | Chandler, Arizona, United States | — |
| IMA Clinical Research PC Phoenix | Phoenix, Arizona, United States | — |
| Noble Clinical Research | Tucson, Arizona, United States | — |
| University of Arizona | Tucson, Arizona, United States | — |
| CI Trials | Bellflower, California, United States | — |
| Wake Research PRI Encino | Encino, California, United States | — |
| National Institute Of Clinical Research | Garden Grove, California, United States | — |
| WR-Newport Beach | Newport Beach, California, United States | — |
| ATP Clinical Research | Orange, California, United States | — |
| Anderson Clinical Research | Redlands, California, United States | — |
| Artemis Institute for Clinical Research | San Diego, California, United States | — |
+ 32 more locations — full list on the registry record.
Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.
We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.